Page last updated: 2024-08-18

phenformin and Colorectal Neoplasms

phenformin has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazelier, MT; de Vries, F; Dittrich, ST; Henry, RM; Knapen, LM; Neef, C; Starup-Linde, J; Stolk, LM; Vestergaard, P1
Alessi, DR; Din, FV; Dunlop, MG; Green, KA; Houde, VP; Sakamoto, K; Valanciute, A; Zibrova, D1

Other Studies

2 other study(ies) available for phenformin and Colorectal Neoplasms

ArticleYear
Use of biguanides and the risk of colorectal cancer: a register-based cohort study.
    Current drug safety, 2013, Volume: 8, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biguanides; Cohort Studies; Colorectal Neoplasms; Comorbidity; Denmark; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Netherlands; Phenformin; Population; Registries; Risk Factors; Young Adult

2013
Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells.
    Gastroenterology, 2012, Volume: 142, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autophagy; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Female; Humans; Intestinal Mucosa; Mice; Mice, Knockout; Phenformin; Phosphoproteins; Phosphorylation; Ribosomal Protein S6; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors

2012